The Testa Center, a new Swedish test-bed infrastructure focused on biopharmaceutical manufacturing, will open June 2018 at GE Healthcare’s Uppsala site. The new center is part of the Swedish government’s initiative to further accelerate the country as one of the global leaders in the R&D and production of biopharmaceutical products. It is a collaboration project … Continue reading A new national infrastructure for verifying bioprocessing technologies